GLA and Fabry disease: Hematopoietic Stem/Progenitor Cell (HSPC)-mediated gene therapy: This treatment method often uses Lentiviruses to deliver the normal GLA gene to autologous HSPCs obtained from the patient’s body, which are then re-infused into the patient to treat FD.